Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.45    -0.20 (-1.20%)
Bid:
16.45
Ask:
16.70
Spread: 0.25 (1.52%)
Market Cap: £131.85m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Trading Update

1 Oct 2012 13:14

RNS Number : 6068N
Allocate Software PLC
01 October 2012
 



 

1 October 2012

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

Trading Update

 

Allocate Software, (AIM: ALL), the leading provider of workforce optimisation and corporate governance, risk & compliance software gives the following update on trading for the first three months of the current financial year ending 31 May 2013.

 

New licence sales have been lower than expected during the first quarter, which historically is the weakest period due to the summer slowdown, particularly in our UK healthcare business. This was as a result of delays in contracts closing, not competitive losses, and therefore the current pipeline for new business wins and licence renewals remains strong. The timing will have a knock-on effect on implementation and support revenues in the current quarter.

 

Progress in our growing portfolio of subscription-based product lines has been encouraging, with a number of these performing above management expectation, most notably our new Allocate Cloud service which we launched during the first quarter. It is however a function of the subscription model that the revenues from new business wins, recognised rateably over an extended period, will not significantly offset the impact of reduced licence and services revenues in the first half, though it does provide a more secure basis for the business in the longer term.

 

As a result of these factors and the changing business mix, the Board now expects that first half revenues will be lower than its original expectations, albeit broadly in line with the first half of the last financial year, and EBITDA will be below the prior year first half comparable.

 

Ian Bowles, Chief Executive, commented: "The Board continues to believe that the Company's new business pipeline and prospects remain strong, and will continue to drive the business towards meeting its financial targets for the full year. Whilst it is not possible to be certain that the first half revenue shortfall will be fully recouped in the second half, any resulting impact on profits will likely be mitigated by tight control over operating expenditure."

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

 

Tel: +44 (0) 20 7355 5555

Numis Securities Limited (NOMAD / Corporate Broker)

Nominated adviser - Michael Meade / Simon Willis /

Richard Thomas

Corporate Broking - James Black

 

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

John Bick

 

Tel: +44 (0) 20 7193 7463

+44 (0) 7525 324 431

 

 

 

About Allocate Software plc

Allocate Software plc is the leading workforce and compliance optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare and Defence.

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.Allocatesoftware.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUAAURURARRAA
Date   Source Headline
30th Mar 20237:00 amRNSConference Attendance
24th Mar 20237:00 amRNSCorporate Update - Director/PDMR Shareholding
22nd Mar 20237:00 amRNSDefinitive Feasibility Study Project Update
20th Mar 20237:00 amRNS2023 Exploration and Resource Programmes Update
20th Mar 20237:00 amRNSDirector/PDMR Shareholding
17th Mar 20237:05 amRNSInvestor Presentation
17th Mar 20237:00 amRNSHolding(s) in Company
15th Mar 20237:00 amRNSCorporate Update and Half-year Financial Report
9th Mar 20238:15 amRNSRestoration - Atlantic Lithium Limited
9th Mar 20238:00 amRNSResponse to Online Report & Restoration of Trading
8th Mar 20234:15 pmRNSSuspension - Atlantic Lithium Limited
1st Mar 20238:00 amRNSResults of Extraordinary General Meeting
21st Feb 20237:00 amRNSCommunications Update - Conference Attendance
17th Feb 20237:00 amRNSExpression of Interest - Investment by MIIF
13th Feb 20239:00 amRNSRicca Resources - Pre-IPO Placement
3rd Feb 20238:00 amRNSCorporate Communication Update Mining Indaba 2023
1st Feb 20237:00 amRNSEwoyaa Mineral Resource increases to 35.3Mt
31st Jan 20237:00 amRNSNotice of Extraordinary General Meeting
30th Jan 20237:00 amRNSQuarterly Activities and Cash Flow Report Dec 2022
20th Jan 20237:00 amRNSCorporate Update – 2023 OTCQX Best 50 - ALLIF
12th Jan 20237:00 amRNSFinal Assay Results and New High-Grade pegmatites
30th Dec 20228:00 amRNSCorporate Update Change of terms for Share Options
13th Dec 20227:00 amRNSPrimero awarded FEED Contract for Ewoyaa Lithium
5th Dec 20227:00 amRNSCommunication Update - LSE Investor Webinar
30th Nov 20227:15 amRNSCorporate Update - Result of 2022 AGM
29th Nov 20227:00 amRNSHigh-Grade Drill Results - Highest Grade to Date
28th Nov 20227:00 amRNSAppointment of Alternate Director
28th Nov 20227:00 amRNSCommencement of COO and Issue of Options
22nd Nov 20227:00 amRNSTR1 Notification of Major Holdings
16th Nov 20227:00 amRNSCorporate Update - Mines & Money London 2022
9th Nov 20227:38 amRNSSignificant Potential for Resource Upgrades
2nd Nov 20227:00 amRNSHighest Reported Grade to Date of 4.52% Li2O
31st Oct 20227:00 amRNSNotice of AGM
27th Oct 20227:10 amRNSAppointment of Chief Operating Officer
27th Oct 20227:05 amRNSQuarterly Activities and Cash Flow Report
27th Oct 20227:00 amRNSInvestor Presentation for Webinar
21st Oct 20227:00 amRNSCorporate Communication Update - Investor Webinar
20th Oct 20227:00 amRNSOngoing High-Grade Lithium Intersections at Ewoyaa
13th Oct 20227:00 amRNSMining Licence Application Lodged for Ewoyaa
12th Oct 20227:00 amRNSCorporate Update - Conference Attendance
30th Sep 20227:30 amRNSCorporate Update – 2022 Annual Financial Report
28th Sep 202210:00 amRNSPiedmont Partner Atlantic Lithium Completes PFS
26th Sep 202210:00 amRNSASX Listing – Commencement of Trading
22nd Sep 20227:00 amRNSRobust Ewoyaa Pre-Feasibility Study
21st Sep 20227:01 amRNSASX Listing – Admission to Official List
19th Sep 20227:00 amRNSCorporate Update - Issue of Equity / PCA Dealings
16th Sep 20222:00 pmRNSTR1 Notification of Significant Shareholding
8th Sep 202210:00 amRNSCorporate Update Dual Listing – Close of ASX Offer
30th Aug 202212:00 pmRNSCorporate Communication Update - Africa Down Under
30th Aug 202210:00 amRNSLodgement of Dual Listing Replacement Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.